SecBot SecBot
3 ·Filed Jul 15, 2026

FULC

Fulcrum Therapeutics, Inc.
BULLISH
Impact 6/10
Horizondays Processed4mo ago SEC0001178579-26-000013
Actionable Insight ▲ Bullish

Monitor for a Schedule 13D filing, which would detail Tang Capital's intentions (e.g., pushing for a sale, board changes, or strategic review). The stake size (~2.8% of shares outstanding at $239M market cap) is significant enough to command attention. Look for increased trading volume and potential short squeeze given the high bearish analyst sentiment.

DirectionBullish
Confidencemedium
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.50
T+0 close · Jul 15, 2026 · via day close
Latest settled
+7.71%
T+60 · $3.77
Vs SPY
+4.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 16 $3.50entry
  2. T+1 · 4mo ago +4.29%α +5.28% · $3.65
  3. T+5 · 4mo ago +7.43%α +9.10% · $3.76
  4. T+20 · 3mo ago +6.00%α +2.38% · $3.71
  5. T+60 · 6w ago +7.71%α +4.00% · $3.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Kevin Tang and Tang Capital Management LLC filed a Form 3 initial statement of beneficial ownership, disclosing a 6,663,383-share stake in Fulcrum Therapeutics. This represents a new, significant position by a known activist investor, suggesting potential strategic engagement at a beaten-down biotech with a $239M market cap and largely negative analyst consensus.

Key Facts

  • Kevin Tang and Tang Capital Management LLC filed Form 3 on 2026-07-15, reporting beneficial ownership of 6,663,383 shares of FULC common stock.
  • The shares are held indirectly through Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc.
  • Kevin Tang is the sole manager/director/CEO of the reporting entities, giving him control and pecuniary interest in the stake.
  • The filing is an initial statement, indicating a new position by Tang Capital, a known activist investment firm.
  • FULC has a $239M market cap and 0% analyst bullish rating (7 hold, 4 sell, 2 strong sell).

Financial Impact

6,663,383 shares of FULC common stock disclosed; no specific dollar value for the stake is provided in the filing.

ownershipshares outstanding

Risk Factors

  • Tang Capital's intentions are unclear from this Form 3 alone; no 13D has been filed yet.
  • The company's weak fundamentals and negative analyst consensus could limit upside if Tang Capital fails to drive a clear outcome.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (FULC), Batch item 10001178579-26-000013
Document: 0001178579-26-000013-index.html0001178579-26-000013
Document: 0001178579-26-000013.txt0001178579-26-000013
3 Filing (FULC), Batch item 40001178579-26-000013
Document: 0001178579-26-000013-index.html0001178579-26-000013
Document: 0001178579-26-000013.txt0001178579-26-000013

Track record

23 reports on FULC

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +3.90% at T+20 after the Sep 1, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $3.72 Now $3.71 −0.27% settles Nov 18
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $3.73 Now $3.71 −0.40% settles Nov 17
  3. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $3.77 Now $3.71 −1.59% settles Nov 17
  4. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $3.77 Now $3.71 −1.59% settles Nov 17
  5. Nov 12, 20264d ago 425 Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
  6. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
  7. Nov 5, 202612d ago EFFECT Neutral 4/10 Entry $3.68 to $3.70 Now $3.71 +0.82% ▲ +0.54% +0.23% vs SPY
  8. Nov 3, 202613d ago S-4/A Neutral 5/10 Entry $3.74 to $3.77 Now $3.71 −0.80% ▲ +0.80% −0.85% vs SPY
  9. Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
  10. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 15, 2026